Regina Kay Ting Wong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Regina Kay Ting Wong has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Isabelle Xin Yu Lee
Regenerative Therapy Group, Singapore Eye Research Institute, Singapore 169856, Singapore
4 shared publications - Yu-Chi Liu
Regenerative Therapy Group, Singapore Eye Research Institute, Singapore, Singapore
4 shared publications - Chang Liu
Regenerative Therapy Group, Singapore Eye Research Institute, Singapore 169856, Singapore
3 shared publications - Jipson Hon Fai Wong
Regenerative Therapy Group, Singapore Eye Research Institute, Singapore 169856, Singapore
2 shared publications - Jodhbir Singh Mehta
Regenerative Therapy Research Group, Singapore Eye Research Institute, Singapore 169856, Singapore
2 shared publications - Mingyi Yu
Regenerative Therapy Group, Singapore Eye Research Institute, Singapore, Singapore
2 shared publications
Latest Publications
- Open Access
- 10 November 2026
- Published by Wolters Kluwer Health in Cornea
Reliability and Validity of the Chinese Version of the Ocular Pain Assessment Survey (OPAS-C)
Purpose: Our study aimed to investigate the reliability and validity of a translated Chinese version of the Ocular Pain Assessment Survey (OPAS-C) across different cohorts of ocular surface diseases. Methods: This cross-sectional study included 175 participants, comprising 40 healthy controls, 38 patients with dry eye disease (DED), 46 patients with neuropathic corneal pain (NCP), and 51 patients with diabetes mellitus (DM). The OPAS-C scores were compared between the cohorts for each subscale. The internal consistency was assessed using the Cronbach alpha coefficients, and factor validity was assessed using exploratory factor analysis (EFA). Results: The NCP cohort had higher scores than other cohorts for most subscales, while the DM cohort consistently had the lowest scores for all subscales (all P < 0.05). All subscales of the OPAS-C demonstrated good to excellent reliability for all cohorts, specifically core ocular pain subscales such as ocular pain intensity (past 2 weeks and 24 hours), interference with quality of life, aggravating and associated factors (Cronbach alpha coefficients: 0.715–0.990). EFA revealed a 3-factor model with all questions loading strongly onto the model (factor loading values: 0.447–1.131). Factor 1 (ocular pain and related symptoms subscale) showed excellent reliability (Cronbach alpha coefficient: 0.974), while factor 2 (aggravating and associated factors subscale) and factor 3 (nonocular subscale) showed very good reliability (Cronbach alpha coefficient: 0.882 and 0.871, respectively). Conclusions: The OPAS-C is thus a reliable and valid tool in evaluating ocular pain symptoms across diverse patient cohorts, offering a culturally adapted assessment by bridging linguistic barriers.
- 10 November 2026
- Published by Wolters Kluwer Health in Cornea
Open AccessReliability and Validity of the Chinese Version of the Ocular Pain Assessment Survey (OPAS-C)
Purpose: Our study aimed to investigate the reliability and validity of a translated Chinese version of the Ocular Pain Assessment Survey (OPAS-C) across different cohorts of ocular surface diseases. Methods: This cross-sectional study included 175 participants, comprising 40 healthy controls, 38 patients with dry eye disease (DED), 46 patients with neuropathic corneal pain (NCP), and 51 patients with diabetes mellitus (DM). The OPAS-C scores were compared between the cohorts for each subscale. The internal consistency was assessed using the Cronbach alpha coefficients, and factor validity was assessed using exploratory factor analysis (EFA). Results: The NCP cohort had higher scores than other cohorts for most subscales, while the DM cohort consistently had the lowest scores for all subscales (all P < 0.05). All subscales of the OPAS-C demonstrated good to excellent reliability for all cohorts, specifically core ocular pain subscales such as ocular pain intensity (past 2 weeks and 24 hours), interference with quality of life, aggravating and associated factors (Cronbach alpha coefficients: 0.715–0.990). EFA revealed a 3-factor model with all questions loading strongly onto the model (factor loading values: 0.447–1.131). Factor 1 (ocular pain and related symptoms subscale) showed excellent reliability (Cronbach alpha coefficient: 0.974), while factor 2 (aggravating and associated factors subscale) and factor 3 (nonocular subscale) showed very good reliability (Cronbach alpha coefficient: 0.882 and 0.871, respectively). Conclusions: The OPAS-C is thus a reliable and valid tool in evaluating ocular pain symptoms across diverse patient cohorts, offering a culturally adapted assessment by bridging linguistic barriers.
- Open Access
- 15 July 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (14) , 1785
Evaluation of Corneal Sensitivity: Tools We Have
Corneal sensitivity is an important indicator of corneal health and innervation. Corneal hypoesthesia may be an early indicator of corneal diseases such as neurotrophic keratopathy. Various instruments have been used to measure corneal sensitivity, the first being the Cochet–Bonnet aesthesiometer. Over the years, new devices employing different stimuli have been developed, such as the gas-based Belmonte aesthesiometer, the Swiss liquid-jet aesthesiometer, and the most recently released corneal Brill aesthesiometer. In this review, the progress and advancement of aesthesiometers since their introduction is described. The mechanism, advantages, and disadvantages of these aesthesiometers are discussed and compared. We also report the relationship between corneal sensitivity and corneal innervation in various conditions, including diabetes mellitus, Fuchs’ endothelial dystrophy, dry eye disease, glaucoma, keratoconus, herpes simplex keratitis, post-refractive surgery, and ocular graft-versus-host disease. Through this review, we aim to highlight the importance of the assessment of corneal sensitivity and innervation in the diagnosis, treatment, and monitoring of anterior and posterior segment ocular disorders.
- 15 July 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (14) , 1785
Open AccessEvaluation of Corneal Sensitivity: Tools We Have
Corneal sensitivity is an important indicator of corneal health and innervation. Corneal hypoesthesia may be an early indicator of corneal diseases such as neurotrophic keratopathy. Various instruments have been used to measure corneal sensitivity, the first being the Cochet–Bonnet aesthesiometer. Over the years, new devices employing different stimuli have been developed, such as the gas-based Belmonte aesthesiometer, the Swiss liquid-jet aesthesiometer, and the most recently released corneal Brill aesthesiometer. In this review, the progress and advancement of aesthesiometers since their introduction is described. The mechanism, advantages, and disadvantages of these aesthesiometers are discussed and compared. We also report the relationship between corneal sensitivity and corneal innervation in various conditions, including diabetes mellitus, Fuchs’ endothelial dystrophy, dry eye disease, glaucoma, keratoconus, herpes simplex keratitis, post-refractive surgery, and ocular graft-versus-host disease. Through this review, we aim to highlight the importance of the assessment of corneal sensitivity and innervation in the diagnosis, treatment, and monitoring of anterior and posterior segment ocular disorders.
- Open Access
- 8 January 2025
- Published by MDPI AG in Bioengineering
- Vol. 12 (1) , 45
The Application of Terahertz Technology in Corneas and Corneal Diseases: A Systematic Review
Terahertz (THz) waves reside in the electromagnetic spectrum between the microwave and infrared bands. In recent decades, THz technology has demonstrated its potential for biomedical applications. With the highly unique characteristics of THz waves, such as the high sensitivity to water and optimal spatial resolution coupled with the characteristics of the human cornea, such as its high water content, THz technology has been explored as a potential modality to assess corneas and corneal diseases. This systematic review provides an overview of the characteristics of THz waves, the safety profile of THz technology in the field of ophthalmology, and its clinical applications, including the objective evaluation of the corneal hydration, tear film, dry eye disease, corneal endothelium, corneal elasticity, and scarring. The paper also presents our viewpoint on the present challenges and future directions of THz technology prior to its broader integration into clinical practice.
- 8 January 2025
- Published by MDPI AG in Bioengineering
- Vol. 12 (1) , 45
Open AccessThe Application of Terahertz Technology in Corneas and Corneal Diseases: A Systematic Review
Terahertz (THz) waves reside in the electromagnetic spectrum between the microwave and infrared bands. In recent decades, THz technology has demonstrated its potential for biomedical applications. With the highly unique characteristics of THz waves, such as the high sensitivity to water and optimal spatial resolution coupled with the characteristics of the human cornea, such as its high water content, THz technology has been explored as a potential modality to assess corneas and corneal diseases. This systematic review provides an overview of the characteristics of THz waves, the safety profile of THz technology in the field of ophthalmology, and its clinical applications, including the objective evaluation of the corneal hydration, tear film, dry eye disease, corneal endothelium, corneal elasticity, and scarring. The paper also presents our viewpoint on the present challenges and future directions of THz technology prior to its broader integration into clinical practice.
- Open Access
- 20 August 2024
- Published by Wolters Kluwer Health in Cornea
- Vol. 44 (7) , 825-831
Quality of Life and Symptomatology in Neuropathic Corneal Pain in Comparison With Dry Eye Syndrome
Purpose: To investigate and compare the quality of life (QoL) and symptomatology between neuropathic corneal pain (NCP) and dry eye disease (DED). Methods: We recruited 150 patients, comprising 50 patients with NCP and 100 patients with DED. Patients’ symptoms and QoL were evaluated using the Ocular Pain Assessment Survey and Ocular Surface Disease Index questionnaires. Ocular surface assessments were also performed. Results: Patients with NCP demonstrated significantly lower Oxford and National Eye Institute scores for ocular surface and corneal staining, respectively, and a better tear break-up time than patients with DED. However, patients with NCP reported significantly worse scores on most of the Ocular Pain Assessment Survey questions and significantly more severe overall pain (P = 0.019), maximal and average ocular pain and nonocular pain (all P < 0.05). The NCP group reported significantly worse QoL in all aspects of daily living (all P < 0.001). Patients with NCP spent more time thinking about their eye pain and reported significantly higher pain intensities than patients with DED when exposed to chemical and mechanical stimuli (all P ≤ 0.008). Burning sensation and photophobia were significantly more frequent in patients with NCP (P = 0.032 and P = 0.012, respectively). Similarly, the NCP group reported significantly worse total Ocular Surface Disease Index scores, significantly more frequent vision-related function impairment and painful or sore eyes than the DED group (P = 0.029, P = 0.031, and P = 0.014, respectively). Conclusions: Compared with DED, NCP is more debilitating, leading to more severe and frequent symptoms, and greater negative impact on all aspects of QoL.
- 20 August 2024
- Published by Wolters Kluwer Health in Cornea
- Vol. 44 (7) , 825-831
Open AccessQuality of Life and Symptomatology in Neuropathic Corneal Pain in Comparison With Dry Eye Syndrome
Purpose: To investigate and compare the quality of life (QoL) and symptomatology between neuropathic corneal pain (NCP) and dry eye disease (DED). Methods: We recruited 150 patients, comprising 50 patients with NCP and 100 patients with DED. Patients’ symptoms and QoL were evaluated using the Ocular Pain Assessment Survey and Ocular Surface Disease Index questionnaires. Ocular surface assessments were also performed. Results: Patients with NCP demonstrated significantly lower Oxford and National Eye Institute scores for ocular surface and corneal staining, respectively, and a better tear break-up time than patients with DED. However, patients with NCP reported significantly worse scores on most of the Ocular Pain Assessment Survey questions and significantly more severe overall pain (P = 0.019), maximal and average ocular pain and nonocular pain (all P < 0.05). The NCP group reported significantly worse QoL in all aspects of daily living (all P < 0.001). Patients with NCP spent more time thinking about their eye pain and reported significantly higher pain intensities than patients with DED when exposed to chemical and mechanical stimuli (all P ≤ 0.008). Burning sensation and photophobia were significantly more frequent in patients with NCP (P = 0.032 and P = 0.012, respectively). Similarly, the NCP group reported significantly worse total Ocular Surface Disease Index scores, significantly more frequent vision-related function impairment and painful or sore eyes than the DED group (P = 0.029, P = 0.031, and P = 0.014, respectively). Conclusions: Compared with DED, NCP is more debilitating, leading to more severe and frequent symptoms, and greater negative impact on all aspects of QoL.